TALOS: A multicenter, randomized, double-blind, placebo-controlled trial to test the effects of citalopram in patients with acute stroke

International Journal of Stroke

Volumn 10, Issue 6, 2015, Pages 985-987

  Kraglund, Kristian Lundsgaard ^a   Mortensen, Janne Kaergaard ^a   Grove, Erik Lerkevang ^a   Johnsen, Søren Paaske ^a   Andersen, Grethe ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Acute ischemic stroke; Clinical trials; Neuroprotection; Protocols; Randomized controlled trial; SSRI

Indexed keywords

ALTEPLASE; CITALOPRAM; PLACEBO; NEUROPROTECTIVE AGENT; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGED; ARTICLE; BARTHEL INDEX; BRAIN INFARCTION SIZE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE ASSESSMENT; DISEASE SEVERITY; DRUG ACTIVITY; DRUG EFFICACY; FUNCTIONAL STATUS; GOOD CLINICAL PRACTICE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MINI MENTAL STATE EXAMINATION; MODIFIED RANKIN SCORE; MORTALITY; MULTICENTER STUDY; NEUROPROTECTION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TRANSIENT ISCHEMIC ATTACK; BRAIN ISCHEMIA; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; FOLLOW UP; MENTAL HEALTH; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; PATIENT SELECTION; SEVERITY OF ILLNESS INDEX; STROKE; TREATMENT OUTCOME;

BRAIN ISCHEMIA; CITALOPRAM; DOUBLE-BLIND METHOD; FOLLOW-UP STUDIES; HUMANS; MENTAL STATUS SCHEDULE; MYOCARDIAL INFARCTION; NEUROPROTECTIVE AGENTS; PATIENT SELECTION; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; STROKE; TREATMENT OUTCOME;

EID: 84938214191     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/ijs.12485     Document Type: Article

References (15)

1. Gershon M, Tack J. The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology 2007; 132:397-414.
2. Jacobs B, Azmitia C. Structure and Function of the Brain Serotonin System. Physiol Rev 1992; 72:165-229.
3. Berger M, Gray JA, Roth BL. The expanded biology of serotonin. Annu Rev Med 2009; 60:355-366.
4. Mead G, Hsieh C, Lee R etal. Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery (Review). Cochrane Database Syst Rev 2013; (8):CD009286.
5. Andersen G. Post-Stroke Depression and Pathological Crying: a Population Based Study. Aarhus, Neurological Department, Aarhus University, 1998:55.
6. Lim C-M, Kim S-W, Park J-Y, Kim C, Yoon SH, Lee J-K. Fluoxetine affords robust neuroprotection in the postischemic brain via its anti-inflammatory effect. J Neurosci Res 2009; 87:1037-1045.
7. Chollet F, Tardy J, Albucher JF etal. Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial. Lancet Neurol 2011; 10:123-130.
8. Møller M, Andersen G, Gjedde A. Serotonin 5HT1A receptor availability and pathological crying after stroke. Acta Neurol Scand 2007; 116:83-90.
9. Hergovich N, Aigner M, Eichler HG, Entlicher J, Drucker C, Jilma B. Paroxetine decreases platelet serotonin storage and platelet function in human beings. Clin Pharmacol Ther 2000; 68:435-442.
10. Javors MA, Houston JP, Tekell JL, Brannan SK, Frazer A. Reduction of platelet serotonin content in depressed patients treated with either paroxetine or desipramine. Int J Neuropsychopharmacol 2000; 3:229-235.
11. Mortensen J, Larsson H, Johnsen S, Andersen G. Post stroke use of selective serotonin reuptake inhibitors and clinical outcome among patients with ischemic stroke: a nationwide propensity score-matched follow-up study. Stroke 2013; 44:420-426.
12. Marieb EN. Essentials of Human Anatomy and Physiology, 8th edn. San Francisco, CA, Pearson/Benjamin Cummings, 2006.
13. Berge E, Barer D. Could Stroke trials be missing important treatment effects? Cerebrovasc Dis 2002; 13:73-75.
14. Churilov L, Arnup S, Johns H etal. An improved method for simple, assumption-free ordinal analysis of the modified Rankin Scale using generalized odds ratios. Int J Stroke 2014; 9:999-1005.
15. Murray G, Barer D. Design and analysis of phase III trials with ordered outcome scales: the concept of the sliding dichotomy. J Neurotrauma 2005; 22:511-517.